Medicare Enrolled
Dr. Joseph Urash, D.O.
Dermatology · Shelby, NC
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Urash from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Urash?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Urash
Dr. Joseph Urash is a dermatology specialist in Shelby, NC, with 18 years of NPI registration. Based on federal Medicare data, Dr. Urash performed 68,779 Medicare services across 2,966 unique beneficiaries.
Between the years covered by Open Payments, Dr. Urash received a total of $10,507 from 41 pharmaceutical and/or device companies across 560 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in dermatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Urash is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ Top 0% volume in NC
$10,507 industry payments
Medicare Practice Summary
Medicare Utilization ↗68,779
Medicare services
Top 0% in NC for dermatology
2,966
Unique beneficiaries
$4
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~3,821 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Photodynamic therapy gel for precancerous skin | 64,800 | $1 | $2 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,304 | $56 | $118 |
| Destruction of precancerous skin growths, 2-14 This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer. |
630 | $4 | $26 |
| Destruction of precancerous skin growth, 1 Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer. |
413 | $40 | $143 |
| Skin biopsy, tangential A procedure to remove a sample of the first identified skin growth for laboratory examination. |
301 | $67 | $145 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
294 | $1 | $7 |
| Light therapy to destroy precancerous skin growth A qualified healthcare professional applies light to the skin to destroy precancerous growths. |
232 | $165 | $375 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
122 | $67 | $215 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
122 | $26 | $91 |
| Light therapy to destroy precancerous skin growth This procedure uses light to treat and remove precancerous skin lesions. It is a method for destroying abnormal skin cells before they become cancerous. |
93 | $63 | $260 |
| Surgical removal of facial skin cancer, 1.1-2.0 cm This procedure involves the surgical excision of a cancerous skin growth located on the face, ears, eyelids, nose, lips, or mouth. The size of the removed tissue is between 1.1 and 2.0 centimeters. |
64 | $120 | $521 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
64 | $9 | $35 |
| Additional skin growth biopsy Removal of a sample of an additional skin growth for laboratory examination. This code is used for each extra lesion biopsied during the same session. |
56 | $34 | $80 |
| Intermediate wound repair, 2.6-7.5 cm A medical procedure to close a wound on the scalp, underarms, trunk, arms, or legs that measures between 2.6 and 7.5 centimeters. This type of repair involves cleaning the wound and stitching it closed to promote healing. |
50 | $216 | $547 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
44 | $81 | $189 |
| Surgical removal of skin cancer, 1.1-2.0 cm Surgical excision of a cancerous skin growth measuring between 1.1 and 2.0 centimeters on the body, arms, or legs. |
41 | $94 | $423 |
| Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.6-5.0 cm | 41 | $233 | $527 |
| Injection into skin growths, 1-7 A procedure involving the injection of medication into one to seven skin growths. |
34 | $35 | $104 |
| Ear tissue biopsy A procedure to remove a small sample of tissue from the ear for laboratory examination. |
23 | $54 | $215 |
| Punch biopsy of first skin growth A small, circular piece of skin is removed from a skin growth using a circular blade. The sample is then sent to a laboratory for examination. |
14 | $85 | $185 |
| Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 5.1-7.5 cm | 14 | $245 | $566 |
| Removal of noncancer skin growth, 1.1-2.0 cm This procedure involves the surgical removal of a benign skin growth located on the body, arms, or legs. The growth measured between 1.1 and 2.0 centimeters in diameter. |
12 | $94 | $326 |
| Destruction of cancer skin growth, 1.1-2.0 cm Removal of a cancerous skin growth on the trunk, arms, or legs that measures between 1.1 and 2.0 centimeters. |
11 | $128 | $299 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$10,507
Total received (2018-2024)
Avg $1,501/year across 7 years
Top 17% in NC for dermatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
41
Companies
560
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,990 (95.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$517 (4.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,884
2023
$1,939
2022
$1,225
2021
$1,407
2020
$804
2019
$1,582
2018
$1,667
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$416
UCB, Inc.
$260
Janssen Biotech, Inc.
$194
Biofrontera Inc.
$193
Regeneron Healthcare Solutions, Inc.
$135
SUN PHARMACEUTICAL INDUSTRIES INC.
$116
Boehringer Ingelheim Pharmaceuticals, Inc.
$105
Novartis Pharmaceuticals Corporation
$85
LEO Pharma Inc.
$85
Lilly USA, LLC
$82
Dermavant Sciences, Inc.
$39
Organogenesis Inc.
$37
Genentech USA, Inc.
$32
Amgen Inc.
$28
STRATA Skin Sciences, Inc.
$25
Almirall LLC
$21
E.R. Squibb & Sons, L.L.C.
$17
Galderma Laboratories, L.P.
$16
Top 3 companies account for 46.2% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Biotech, Inc.
$952
AbbVie, Inc.
$879
AbbVie Inc.
$861
UCB, Inc.
$712
ABBVIE INC.
$712
Lilly USA, LLC
$661
Amgen Inc.
$620
Biofrontera Inc.
$546
Novartis Pharmaceuticals Corporation
$492
Genentech USA, Inc.
$429
LEO Pharma Inc.
$427
PFIZER INC.
$394
Regeneron Healthcare Solutions, Inc.
$332
Sun Pharmaceutical Industries Inc.
$274
SUN PHARMACEUTICAL INDUSTRIES INC.
$242
GENZYME CORPORATION
$225
Boehringer Ingelheim Pharmaceuticals, Inc.
$193
Allergan Inc.
$156
Celgene Corporation
$145
Janssen Scientific Affairs, LLC
$122
Dermavant Sciences, Inc.
$121
E.R. Squibb & Sons, L.L.C.
$113
Ortho Dermatologics, a division of Bausch Health US, LLC
$108
Promius Pharma LLC
$84
Sebela Pharmaceuticals Inc.
$76
Mylan Pharmaceuticals Inc.
$70
Allergan, Inc.
$69
Paratek Pharmaceuticals, Inc.
$66
Mayne Pharma Inc.
$63
Galderma Laboratories, L.P.
$53
Almirall LLC
$51
DERMIRA, INC.
$48
STRATA Skin Sciences, Inc.
$38
Organogenesis Inc.
$37
Encore Dermatology Inc.
$29
Mission Pharmacal Company
$28
Fresenius Kabi USA, LLC
$26
Incyte Corporation
$18
Helsinn Therapeutics (U.S.), Inc.
$15
EPI Health, LLC
$13
Journey Medical Corporation
$7
Top 3 companies account for 25.6% of all-time payments
Associated products mentioned in payments ›
ABSORICA LD · ADBRY · AMELUZ · Absorica LD · Ameluz · BLU-U · BOTOX · BOTOX COSMETIC · Bimzelx · CIBINQO · CLODERM · COSENTYX · Cimzia · Clindamycin Phosphate and Benzoyl Peroxide · DERMATITIS - DISEASE · DORYX · DUOBRII · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · EFFEXOR XR · ELIDEL · ENSTILAR · EPIDUO FORTE · EUCRISA · Enbrel · Erivedge · Exelderm · FINACEA · HUMIRA · Humira · IDACIO · ILUMYA · Ilumya · Impoyz · JUBLIA · Klisyri · LIBTAYO · NAFTIN · NUZYRA · ODOMZO (sonidegib) capsules · OLUMIANT · OPZELURA · ORACEA · Olux · Otezla · PICATO · QBREXZA · REMICADE · RINVOQ · SILIQ · SKYRIZI · SPEVIGO · Sernivo Spray · Seysara · Skyrizi · Sotyktu · TALTZ · TREMFYA · TRIANEX 0.05% · Tremfya · Trianex · ULTRAVATE · VALCHLOR · VTAMA · Veltin · Winlevi · XTRAC · Xolair
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (95%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Dermatologists within 10 mi
11
Per 100K population
11.0
County median income
$55,769
Nearest hospital
ATRIUM HEALTH CLEVELAND
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Urash is a mixed practice specialist, with above-average Medicare volume (top 0% in NC), with low-engagement industry engagement in the top 17% of NC peers, with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Urash experienced with photodynamic therapy gel for precancerous skin?
Based on Medicare claims data, Dr. Urash performed 64,800 photodynamic therapy gel for precancerous skin services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Urash receive payments from pharmaceutical companies?
Yes. Dr. Urash received a total of $10,507 from 41 companies across 560 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Urash's costs compare to other dermatologists in Shelby?
Dr. Urash's average Medicare payment per service is $4. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Urash) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Dermatologists in Shelby
Browse dermatologists in Shelby ranked by procedure volume and transparency data.
Highest volume
Top Dermatologists in NC
Dermatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Dermatologists in NC
Which NC dermatologists receive the most from drug and device companies.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
AbbVie, Inc. Payments to Doctors
See all physicians who received payments from AbbVie, Inc.
By company
AbbVie Inc. Payments to Doctors
See all physicians who received payments from AbbVie Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology